As a potential diagnostic and prognostic biomarker, SRSF3 is overexpressed in various types of cancer, including cancer of the breast, retinoblastoma, ovarian cancer, gastric cancer, head and neck cell squamous, colorectal cancer, cervical cancer and hepatocellular carcinoma (HCC). This evidence concerns the gene SRSF3 and gastric cancer.